Fuji Pharma Co., Ltd.
4554.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$46.49B
Close$
Share Statistics
| Market cap | $46.49 Billion |
|---|---|
| Enterprise Value | $65.44 Billion |
| Dividend Yield | $49.00 (2.75%) |
| Earnings per Share | $122.93 |
| Beta | 0.33 |
| Outstanding Shares | 26,119,761 |
Return
| Return on Equity | 5.76% |
|---|---|
| Return on Assets | 3.04% |
| Return on Invested Capital | 10.72% |
Valuation & Multiples
| P/E Ratio | 14.96 |
|---|---|
| PEG | 14.4 |
| Price to Sales | 0.77 |
| Price to Book Ratio | 0.9 |
| Enterprise Value to Revenue | 1.09 |
| Enterprise Value to EBIT | 9.33 |
| Enterprise Value to Net Income | 21 |
| Total Debt to Enterprise | 0.44 |
| Debt to Equity | 0.56 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$15.78 B
Average shareholder expectationNext Earnings Call
Expected Date
November 10, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$17.62 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Fuji Pharma Co., Ltd.
1,760 employees
CEO: Shuhei Morita Fuji Pharma Co., Ltd. is a pharmaceutical company that operates globally, focusing on the complete spectrum of drug development, from initial research and discovery through manufacturing and commercialization. Its comprehensive product l...